Stock GSK GLAXOSMITHKLINE PLC
Add to a list
To use this feature you must be a member
Log inSign up

Calendar GlaxoSmithKline plc LIQUIDNET SYSTEMS

Equities

GSK

GB0009252882

Delayed LIQUIDNET SYSTEMS
Other stock markets
 		5-day change 1st Jan Change
- EUR -.--% Intraday chart for GlaxoSmithKline plc -0.40% -.--%
17/06 GSK : Jefferies reiterates its Buy rating ZD
17/06 GSK: Phase III study with iTeos begins CF

Chart calendar GlaxoSmithKline plc

986863cc50cba770c2d1ed1.9hwXjR6EdcsS8ssPdLCA9pUx-LsZw1oLHqesOMfaT_0.gSsi40yxM7pVsYE6G8Trm61BofVBjSxHWN2Bb5-LOs-7aDrnZ_0thCScng~3cf710f648474706843a38e9e3480f0b

Upcoming events on GlaxoSmithKline plc

31/07/2024 11:30 am Q2 2024 Earnings Release
30/10/2024 11:30 am Q3 2024 Earnings Release
05/02/2025 12:30 pm Q4 2024 Earnings Release
30/04/2025 Q1 2025 Earnings Release (Projected)
23/07/2025 Q2 2025 Earnings Release (Projected)
29/10/2025 Q3 2025 Earnings Release (Projected)
11/02/2026 Q4 2025 Earnings Release (Projected)

Past events on GlaxoSmithKline plc

17/06/2024 05:30 pm Analyst Meeting - Getting Ahead of Cancer
06/06/2024 BNP Paribas Exane CEO Conference
31/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #8627
31/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #LBA3512
31/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #8017
31/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #7530
31/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #TPS5627
31/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #e19523
31/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #TPS6125
31/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #e19532
31/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #e19524
31/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #e19507
31/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #e19503
31/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #7559
31/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #e23110
31/05/2024 American Society of Clinical Oncology Meeting - MV. Mateos
31/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #7503
31/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #7543
31/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #5606
31/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #5607

Past dividends on GlaxoSmithKline plc

16/05/2024 Interim Payment 0.15 GBP
22/02/2024 Final Payment 0.16 GBP
16/11/2023 Interim Payment 0.14 GBP
17/08/2023 Interim Payment 0.14 GBP
18/05/2023 Interim Payment 0.14 GBP
23/02/2023 Final Payment 0.1375 GBP
17/11/2022 Interim Payment 0.1375 GBP
18/08/2022 Interim Payment 0.1625 GBP
18/07/2022 0 GBP
19/05/2022 Interim Payment 0.14 GBP

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million GBP		Released
Forecast
Spread 		33 754
33 382
1.11%		34 099
34 076
0.07%		34 114
34 029
0.25%		29 324
29 105
0.75%		30 328
29 850
1.6%
31 665

EBITDA
Million GBP		Released
Forecast
Spread 		11 968
11 155
7.28%		9 530
10 575
-9.88%		11 330
10 048
12.76%		10 449
9 257
12.88%		11 635
10 203
14.04%
10 629

EBIT
Million GBP		Released
Forecast
Spread 		8 972
9 182
-2.29%		8 906
8 955
-0.55%		8 806
8 717
1.02%		8 151
7 952
2.5%		8 786
8 780
0.07%
9 202

Earnings before Tax (EBT)
Million GBP		Released
Forecast
Spread 		6 221
5 926
4.97%		6 968
6 763
3.02%		5 442
5 794
-6.07%		5 628
5 548
1.45%		6 064
7 498
-19.12%
7 386

Net income
Million GBP		Released
Forecast
Spread 		4 645
4 026
15.38%		5 749
4 894
17.46%		4 385
3 990
9.91%		14 956
6 238
139.74%		4 928
5 481
-10.09%
5 571

EPS
GBP		Released
Forecast
Spread 		1,16
1,06
9.69%		1,43
1,21
17.91%		1,08
1,02
6.28%		3,66
1,66
120.52%		1,22
1,38
-11.61%
1,38

Announcement Date05/02/2003/02/2109/02/2201/02/2331/01/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million GBP		Released
Forecast
Spread 		9 780
9 145
6.94%		6 929
6 906
0.33%		7 829
7 214
8.52%		7 376
7 101
3.88%		6 951
6 580
5.64%		7 178
6 795
5.63%		8 147
7 727
5.43%		8 052
7 621
5.65%		7 363
7 060
4.3%
7 533


8 534


8 219


7 590


7 865

EBITDA
Million GBP		Released
Forecast
Spread 		3 317
2 850
16.4%		2 639
2 138
23.45%		3 561
2 704
31.68%		1 602
1 855
-13.63%		2 732
2 418
12.97%		2 622
2 506
4.64%		3 351
3 072
9.09%		2 930
2 094
39.93%		2 992
2 406
24.36%
2 594


3 095


1 835







EBIT
Million GBP		Released
Forecast
Spread 		2 613
2 291
14.06%		2 008
1 740
15.4%		2 605
2 264
15.08%		1 595
1 509
5.7%		2 092
1 930
8.42%		2 170
1 999
8.56%		2 772
2 570
7.88%		1 752
1 836
-4.58%		2 443
2 099
16.38%
2 216


2 793


1 757


2 408


2 487

Earnings before Tax (EBT)
Million GBP		Released
Forecast
Spread 		2 598
2 268
14.55%		896
1 243
-27.89%		1 012
1 860
-45.59%		1 626
946
71.97%		1 907
1 529
24.72%		1 987
1 500
32.51%		1 791
2 225
-19.51%		379
1 361
-72.15%		1 355
1 696
-20.11%
1 823


2 493


1 317







Net income
Million GBP		Released
Forecast
Spread 		1 802
1 674
7.66%		975
802
21.54%		10 315
1 356
660.76%		1 495
1 151
29.9%		1 490
1 179
26.41%		1 624
1 213
33.86%		1 464
1 739
-15.79%		350
834
-58.04%		1 046
1 297
-19.32%
1 425


1 877


1 214







EPS
GBP		Released
Forecast
Spread 		0,45
0,41
8.83%		0,21
0,21
-3.22%		2,52
0,34
640.73%		0,37
0,19
95.19%		0,37
0,29
27.52%		0,40
0,30
35.52%		0,36
0,43
-15.26%		0,09
0,20
-58.02%		0,25
0,31
-19.17%
0,35


0,46


0,23







Announcement Date27/04/2227/07/2202/11/2201/02/2326/04/2326/07/2301/11/2331/01/2401/05/24-----

Upcoming sector events for GlaxoSmithKline plc

04/07/2024 HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected)
11/07/2024 HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release
16/07/2024 CAMURUS AB: Q2 2024 Earnings Release
17/07/2024 GLAND PHARMA LIMITED: Q1 2025 Earnings Release (Projected)
17/07/2024 04:15 pm JOHNSON & JOHNSON: Q2 2024 Earnings Release
18/07/2024 JUBILANT PHARMOVA LIMITED: Q1 2025 Earnings Release (Projected)
18/07/2024 10:30 am NOVARTIS AG: Q2 2024 Earnings Release
22/07/2024 GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)
22/07/2024 ALMIRALL, S.A.: Q2 2024 Earnings Release
23/07/2024 TORRENT PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)
More events

Past sector events for GlaxoSmithKline plc

14/06/2024 02:51 am EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release
11/06/2024 11:00 am BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release
07/06/2024 04:03 pm SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release
07/06/2024 02:47 pm LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release
30/05/2024 05:38 pm SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release
30/05/2024 04:30 pm ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release
30/05/2024 11:54 am MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release
29/05/2024 05:30 pm FDC LIMITED: Q4 2024 Earnings Release
29/05/2024 02:56 pm JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release
29/05/2024 02:14 pm ALKEM LABORATORIES LIMITED: Q4 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. GSK Stock
  4. GSK Stock
  5. Calendar GlaxoSmithKline plc